Fear of long-term effects: Given the ongoing discussions about risks in the medical community, some patients may have concerns about the long-term impact of GLP-1 medications, including dangerous adverse reactions as described on the FDA warning label, like acute kidney injury and hypoglycemia
The body is an interconnected network of blood vessels and nerves
Phase 4: Maintenance optimization (weeks 25 onward) This is where individual adjustment matters most
Until FDA approval, our priority remains offering patients safe, effective, accessible weight-loss solutions that work today. Other Non-Surgical Weight-Loss Options (Available NOW at Florida Surgery & Weight Loss) Tirzepatide (Mounjaro, Zepbound) Semaglutide (Ozempic, Wegovy) Compounded GLP-1/GIP peptides (where legally eligible) Nutritional planning & coaching Medical weight-loss evaluation Post-weight-loss surgery (Panniculectomy) options The medication does not walk the path for the patient
Not for medical, household or any other uses, for lab use only, Please test before use
Yes, clinical trials are investigating GLP-1 receptor agonists for neurodegenerative conditions including Alzheimer's and Parkinson's disease, based on preclinical evidence suggesting potential neuroprotective properties